Topographic maps of difference in theta power between breathing conditions. حسب Anita B. Frohlich (20660615)

الموضوعات:

Primary data. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Original data2. حسب Lan Zeng (638254)

الموضوعات:

Original data1. حسب Lan Zeng (638254)

الموضوعات:

Variations in slope utilization by a female red panda across different time periods and in comparison with their wild individuals. Different capital letters indicated significant d... حسب Yanshan Zhou (14131359)

الموضوعات:

Variations in altitude utilization by a female red panda across different time periods and in comparison with wild individuals. Different capital letters indicated significant diff... حسب Yanshan Zhou (14131359)

الموضوعات:

Variations in aspect utilization by a female red panda across different time periods and in comparison with wild individuals. Different capital letters indicated significant differ... حسب Yanshan Zhou (14131359)

الموضوعات:

Demographic information. حسب Silas Manning (22693338)

الموضوعات:

Characteristics of JIA patients. حسب Yasmine Makhlouf (17409866)

الموضوعات:

List of excluded articles. حسب Yasmine Makhlouf (17409866)

الموضوعات:

S1 File - حسب Michael Gulledge (20577135)

الموضوعات:

Results for the asymmetric relationship between military expenditures and DOD energy consumption. حسب Ryan P. Thombs (9138968)

الموضوعات:

Coefficient plot of short-run effects. حسب Ryan P. Thombs (9138968)

الموضوعات:

Seven forecast scenarios. حسب Ryan P. Thombs (9138968)

الموضوعات:

Annual Difference in Energy Consumption Relative to Historical Median Change by 2032. حسب Ryan P. Thombs (9138968)

الموضوعات:

Coefficient plot of long-run effects. حسب Ryan P. Thombs (9138968)

الموضوعات:

Results for the asymmetric relationship between military expenditures and DOD energy consumption. حسب Ryan P. Thombs (9138968)

الموضوعات:

Time series of military expenditures and DOD energy consumption. حسب Ryan P. Thombs (9138968)

الموضوعات:

Forecast for each scenario, 2023-2032. حسب Ryan P. Thombs (9138968)

الموضوعات:

Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras حسب Charles W. Parry (20966154)

"…Activating mutations of Ras are one of the most prevalent drivers of cancer and are often associated with poor clinical outcomes. Despite FDA approval for two irreversible inhibitors that target the inactive state of KRas^G12C, significant unmet clinical need still exists, and the susceptibility of non-G12C mutants to inactive-state inhibition remains unclear. …"